Shanghai Haohai Biological Technology updates on H-share buybacks

Shanghai Haohai Biological Technology Co., Ltd. submitted its next day disclosure return on November 27, 2025. The announcement details changes in both H-shares and A-shares, as well as a share buyback report for H-shares. As of November 27, 2025, the total number of issued H-shares (excluding treasury shares) stood at 38,529,240, with no treasury shares held. For A-shares, the total issued (excluding treasury shares) was 190,203,760, with 3,848,095 treasury shares, resulting in a total of 194,051,855 issued shares.

The company conducted H-share buybacks on November 27, 2025, purchasing 78,900 H-shares on the exchange. The buyback occurred at prices ranging from HK$27.64 to HK$27.98 per share, with a total expenditure of HK$2,199,366. This brings the cumulative number of shares repurchased under the current authorization to 1,637,200.

The resolution for the buyback authorization was passed on June 10, 2025, allowing for the repurchase of up to 3,914,184 shares. The total shares repurchased represent 4.1827% of the issued shares (excluding treasury shares) as of the resolution date. The company has set a temporary suspension period for new share issues or transfers of treasury shares following the buyback until December 27, 2025.